|
|
 |
|
|
 |
 Print
|
|
Specific Recommendations Issued for Standards Setters September 16, 1997 — The National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP), which is committed to reducing medication errors in health care delivery, has identified several recommendations that, if implemented, can help to reduce errors in which product labeling and package design have been identified as contributing factors. The initial set of recommendations is aimed at regulators, standards-setters, and manufacturers, with further recommendations slated for health professionals, health care facilities and consumers. Among the Council's recommendations are: on caps and ferrules of injectables, restrict printing to warnings only; make intravenous drug name(s) visible on both sides of the container; and, print drug names at least as large as company names and logos. The Council's recommendations are based upon a review of error reports submitted to USP's Medication Error Reporting Program, and are supported by representatives of 16 member organizations from medicine, pharmacy, nursing, industry, government, health care facilities, and standards-setters. Problems cited include inadequate label warnings about proper drug use, lack of prominent placement of drug name and strength, and lack of differentiation between similarly named drugs. The Council intends to promote these recommendations broadly within the regulatory, standards-setting, and pharmaceutical manufacturing communities to encourage their implementation.
Council Recommendation for Manufacturers of Pharmaceuticals and Devices
Council Recommendation for Standards Setters
© 1998–2008 National Coordinating Council for Medication Error Reporting and Prevention. All Rights Reserved. *Permission is hereby granted to reproduce information contained herein provided that such reproduction shall not modify the text and shall include the copyright notice appearing on the pages from which it was copied. |
